CAS: 20970-75-6; 2-Cyano-3-Methylpyridine

相似化合物

4021-07-2 55589-47-4 123811-72-3

上下游产品

CAS号1003-73-2 3-甲基吡啶-N-氧化物 | CAS号773837-37-9 sodium cyanide | CAS号1104027-41-9 N-ethoxy-3-meth... | CAS号7677-24-9 三甲基氰硅烷 | CAS号143-33-9 氰化钠 | CAS号108-99-6 3-甲基吡啶 | CAS号151-50-8 氰化钾 | CAS号1603-40-3 2-氨基-3-甲基吡啶 | CAS号4931-46-8 N-(3-methylpyri... | CAS号68357-21-1 (S)-6,6-dicyano... | CAS号107285-30-3 3-[2-(3-CHLORO-... | CAS号31255-57-9 3-[2-(3-氯苯基)乙基]... | CAS号32998-95-1 3-甲基-吡啶-2-羧酸叔丁酰胺 | CAS号38092-89-6 甲基氯雷他定 | CAS号937648-82-3 3-甲基-2-吡啶甲酰胺 | CAS号85279-30-7 1-(3-甲基-2-吡啶)乙酮 | CAS号79794-75-5 氯雷他定 | CAS号878207-92-2 6-氯-3-甲基-2-吡啶羧酸甲酯 | CAS号690632-33-8 N-羟基-3-甲基吡啶脒 | CAS号65169-63-3 2-氰基-3-甲基-5-硝基吡啶

间戊二烯 以 乙醇 用作溶剂,化学反应生成2-氰基-3-甲基吡啶
参考文献:Fleury,Jean-Pierre,Heterocycles,1980,Vol. 14,# 10,P. 1581-1602
标题:Fleury,Jean-Pierre,Heterocycles,1980,Vol. 14,# 10,P. 1581-1602

专利信息

专利号:US-10927139-B2
优先权日:2012-11-22
标 题:Chemically cleavable group
发明人：ROBILLARD MARC STEFAN; VERSTEEGEN RONNY MATHIEU; TEN HOEVE WOLTER; ROSSIN RAFFAELLA
权利人:TAGWORKS PHARMACEUTICALS B V
摘要:Disclosed is the use of the reactive components of the inverse electron-demand Diels Alder reaction for chemical masking and unmasking in vitro. This can be applied in complex chemical reactions and, particularly in the synthesis of biomolecules, e.g. on solid supports. The reactive components are a dienophile, particularly a trans-cyclooctene, and a diene, particularly a tetrazine.

专利号:NZ-533287-A
优先权日:2001-11-05
标题:The synthesis of the antihistamine, loratadine, from 2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methylpyridine

专利号:US-9771379-B2
优先权日:2015-09-24
标题:N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides
发明人：BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; ZHANG LEI; O'NEILL BRIAN THOMAS
权利人:PFIZER
摘要:The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, n nwherein the variables R 1 , R 2 , R 3 , R 4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:US-8536164-B2
优先权日:2010-12-20
标 题:Fused pyridine compounds as casein kinase inhibitors
发明人：BUTLER TODD W; CHANDRASEKARAN RAMALAKSHMI Y; MENTE SCOT R; SUBRAMANYAM CHAKRAPANI; WAGER TRAVIS T
权利人:BUTLER TODD W; CHANDRASEKARAN RAMALAKSHMI Y; MENTE SCOT R; SUBRAMANYAM CHAKRAPANI; WAGER TRAVIS T; PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: n nand pharmaceutically acceptable salts thereof, wherein X, Y, A, R 4 , n, and R 7 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:CN-1740160-A
优先权日:2005-07-15
标 题 :Synthesis process of loratadine intermediate

专利号:US-9744173-B2
优先权日:2014-04-10
标题 :2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
发明人：BRODNEY MICHAEL AARON; BECK ELIZABETH MARY; BUTLER CHRISTOPHER RYAN; ZHANG LEI; O'NEILL BRIAN THOMAS; BARREIRO GABRIELA; LACHAPELLE ERIK ALPHIE; ROGERS BRUCE NELSEN
权利人:PFIZER
摘要:The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, n nand the variable R 1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.